0480-1246

Thanks to advances in treatment, a diagnosis of myeloma (a type of blood cancer) is no longer the imminent, inevitable death sentence it once was.

But, as a patient, when you’re sat in an oncologist’s office and you hear the word ‘cancer’, it still feels like the end.

Sandoz wanted to create a campaign that communicated a message of hope to newly-diagnosed patients, reframing their expectations, and helping them picture the life that they still have ahead of them.

So, we created a collection of typographic artworks using a date stamp and dates across five years, the average survival of patients receiving treatment, which is much longer than may expect when they first hear their diagnosis.

The typographic artworks brought a patient information booklet and posters to life, showing patients all the days they still had ahead, and all the life those days could add up to.

Oncologists reported that the campaign became an important emotional first step for myeloma patients in accepting they could keep on living with cancer.

The campaign was targeted at myeloma patients who have been prescribed Lenalidomide.

ABPI and EMA regulations.

The campaign was targeted at newly-diagnosed myeloma patients who have been prescribed Lenalidomide, and aimed to reframe patients’ expectations of what their future could look like.